E-mail a copy of 'Moving Fast, Trius Therapeutics Assesses Capital Needs for Late-Stage Clinical Trials' to a friend

* Required Field






Separate multiple entries with a comma. Maximum 5 entries.



Separate multiple entries with a comma. Maximum 5 entries.


E-Mail Image Verification

Loading ... Loading ...